(Q72345231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

Skansén-Saphir U

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Andersson J

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Andersson U

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 April 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

916-922

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Cytokines in autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Clinical uses of intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

https://api.crossref.org/works/10.1002%2FEJI.1830240420

1 reference

7 January 2021

Bacterial toxin-induced cytokine production studied at the single-cell level

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Septic shock induced by group A streptococcal infection: clinical and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Effects of human anti-IL-1 alpha autoantibodies on receptor binding and biological activities of IL-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Pharmacokinetics of intravenous immunoglobulin (Gammagard) in bone marrow transplant patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Immune interferon: a pleiotropic lymphokine with multiple effects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240420

7 January 2021

Identifiers

DOI

10.1002/EJI.1830240420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8149962%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference